Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia

Dyslipidemia is a change (either increase or decrease) of adipose levels within the blood. When there is a significant increase of this, the term hyperlipidemia is used. With a significant decrease, we talk about hypolipoproteinemia. Both hyperlipidemia and hypolipoproteinemia can be classified as either acquired or familial. Familial hyperlipidemia can be classified in five types according to the Fredrickson classification.For this classification see Quispe et al. 2019 https://doi.org/10.5114/aoms.2019.87207. Lipodystrophy is a change (either increase or decrease) of adipose levels within the lipid tissue deposits. Lipodystrophy is classified based on wether the disease is acquired or congenital, but also wether it is geralized (through the entire body) or partial (in specific parts of the body). This classification was based on the following information by Akinci et al. [https://www.ncbi.nlm.nih.gov/books/NBK513130/]

血脂异常是指血液中脂肪水平的变化，无论是增加还是减少。当这种变化显著增加时，我们使用高脂血症这一术语；而当显著减少时，则称为低脂蛋白血症。高脂血症和低脂蛋白血症均可分为获得性或家族性。家族性高脂血症可根据弗雷德里克森分类分为五种类型。关于此分类，请参阅Quispe等人在2019年的研究（https://doi.org/10.5114/aoms.2019.87207）。脂肪萎缩是指脂质组织沉积中脂肪水平的变化，其分类基于疾病是获得性还是先天性，以及疾病是全身性还是局灶性。该分类基于Akinci等人在[https://www.ncbi.nlm.nih.gov/books/NBK513130/]提供的信息。